Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London
· Delayed Price · Currency is GBP · Price in USD 302.86
-2.88 (-0.94%)
At close: Jun 6, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Other - Collaboration Revenue (Pre-FY2023) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other - Collaboration Revenue (Pre-FY2023) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Novartis AG - Collaboration | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Novartis AG - Collaboration Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vir Biotechnology - Collaboration | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vir Biotechnology - Collaboration Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ONPATTRO | 233.13M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ONPATTRO Growth | -27.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| GIVLAARI | 264.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| GIVLAARI Growth | 15.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Regeneron Pharmaceuticals - Collaboration | 327.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Regeneron Pharmaceuticals - Collaboration Growth | 204.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| OXLUMO | 166.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| OXLUMO Growth | 29.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty | 107.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty Growth | 140.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMVUTTRA | 1.09B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMVUTTRA Growth | 66.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roche - Collaboration | 61.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roche - Collaboration Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|